Pimicikamak Cree Nation wildfire evacuees to sleep in warm beds at Ontario hotel Sunday
On Saturday, First Nations leaders from across Manitoba called on the federal, provincial and Winnipeg municipal governments to direct city hotels to make space for community members being displaced by more than two dozen wildfires burning across the province.
The Manitoba government declared a provincial state of emergency on Wednesday, with more than 17,000 evacuees expected to be fleeing wildfires in northern Manitoba.
Pimicikimak Cree Nation was placed under an emergency evacuation order and thousands were forced to leave home as a wildfire burned out of control near the First Nation.
As of Sunday afternoon, that fire was 3,300 hectares in size, according to the most recent fire bulletin from the province.
Community members from Pimicikamak, also known as Cross Lake, were first sent to Norway House Cree Nation, which has been under an evacuation notice since Wednesday. Residents there were told to prepare for evacuation but have not been ordered to leave.
From there, Pimicikamak evacuees were sent to an evacuation centre set up at a soccer complex in north Winnipeg.
Sheena Garrick, who works with Jordan's Principle for Pimicikamak Cree Nation, said conditions at the Winnipeg Soccer Federation North facility are "horrible".
"Everybody's crying, moms are crying, their kids, they want to go home. It's very heartbreaking," she said, adding the crying has been keeping tired evacuees awake.
When the First Nation had the opportunity to send its citizens to a hotel in Niagara Falls, Garrick worked overnight on Saturday to organize a group of 47 people to fill a plane.
The evacuees landed in Hamilton on Sunday morning and each had a comfortable place to sleep that night, Garrick said.
"There was so much relief. Everybody was smiling. Everybody was so happy coming here to a warm meal, knowing they're gonna have a warm bed," she said.
Denny Scott, an officer with Jordan's Principal, said the Pimicikamak evacuees finally had a chance to rest since they were first ordered to leave the First Nation on Wednesday.
"But Cross Lake is coming together as one and we're together as one," Scott said.
Garrick said her phone has been blowing up with questions from community members about when the next plane is going to leave from Winnipeg.
On Sunday, she said two more planes carrying 119 people each were expected to arrive in Ontario.
"The chaos that's going on in Winnipeg right now, it's nothing like that. You're going to come here, you're going to be happy. You're going to be comfortable," she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
13 minutes ago
- CNN
Panicked sea lions dive into water during earthquake
Panicked sea lions dive into water during earthquake A tourist off the coast of Antsiferov Island, Russia, filmed panicked sea lions diving into the water for safety after a powerful 8.8 earthquake struck near Russia's eastern coast and sparked evacuation orders across the Pacific. 00:12 - Source: CNN Tsunami warnings triggered after major earthquake The strongest earthquake on the planet since 2011 has triggered tsunami warnings for parts of Russia, Japan, and Alaska, as well as all of Hawaii. CNN's Will Ripley reports on the 8.8-magnitude quake. 00:41 - Source: CNN Israeli settler kills activist who worked on Oscar-winning film Odeh Hathalin, a prominent Palestinian activist who had worked on an Oscar-winning documentary, was killed on Monday during an attack by Israeli settlers in the occupied West Bank, according to local journalists and officials. CNN's Jeremy Diamond explains video circulated on social media that shows the gunman firing a hand gun in the vicinity of where Hathalin was said to be killed. 01:36 - Source: CNN Fans in England celebrate Women's Euro 2025 final win Fans celebrate in London as England has been crowned champion of Europe for the second successive time after defeating Spain 3-1 on penalties in the Women's Euro 2025 final. 00:30 - Source: CNN Breaking down Israel's aid drops into Gaza In the midst of a hunger crisis in Gaza, Israel and other countries have begun dropping aid by plane into the area. CNN's Nic Robertson breaks down how much effect this measure can offer, while the UN calls for substantial relief to come from aid trucks moving in quickly through open corridors. 01:15 - Source: CNN People fight for scraps of food in Gaza CNN's Nic Robertson reports on the scarce food conditions in Gaza, with children and mothers fighting off starvation as soup kitchens face shortages. 01:46 - Source: CNN 18 people dead after Peru bus accident At least 18 people have died and 24 were injured after a bus overturned in the Province of Junín, in Central Peru. The cause of the accident is still being investigated. 00:28 - Source: CNN Rare snow leopard baby born at UK zoo Video released by Chester Zoo in the United Kingdom shows a rare snow leopard cub taking its first steps. The baby was the first of its kind born at the facility in its 94-year history. Snow leopards are currently listed as 'vulnerable' on the International Union for Conservation of Nature's (IUCN) Red List of Threatened Species. 01:14 - Source: CNN Trump tells Israel to 'finish the job' against Hamas 00:41 - Source: CNN Desperate fishermen risk their lives to get food in Gaza Israel reissued a warning prohibiting anyone from entering Gaza's sea, but hunger drives desperate people to fish. CNN's Jeremy Diamond reports. 02:08 - Source: CNN 'The level of destruction is enormous': Says Cardinal about Gaza Cardinal Pierbattista Pizzaballa, the Latin Patriarch of Jerusalem, recently toured Gaza after what Israel says was stray ammunition that struck Gaza's only Catholic church, killing three people. He recounts what he witnessed with CNN's Erin Burnett. 01:17 - Source: CNN Why are Thailand and Cambodia fighting? Tensions are rising between Thailand and Cambodia over a border dispute that dates back to 1907. CNN's Will Ripley explains how the conflict has escalated. 01:32 - Source: CNN CNN reports from Gaza aid crossing CNN's Nic Robertson is on the scene at the Kerem Shalom border crossing as aid agencies warn of rampant hunger caused by Israel's blockade of Gaza. Gaza's health ministry said on Tuesday that 900,000 children are going hungry, and 70,000 already show signs of malnutrition. Israel denies it is at fault and accuses Hamas of 'engineering' food shortages. 01:39 - Source: CNN Reopening the ancient tunnels 75 feet under Rome CNN's Ben Wedeman was given an exclusive tour of ancient tunnels underneath Rome's Capitoline Hill. The tunnels, which archeologists say were once filled with ancient Roman shops and taverns, are set to open to the public in late 2026 or early 2027. 02:02 - Source: CNN Ukraine sees first major anti-government protests since start of war Hundreds took to the streets after Ukrainian President Volodymyr Zelensky signed a new law limiting the autonomy of anti-corruption agencies in his government. 01:03 - Source: CNN Peruvian police use superhero disguise during drug raid An agent in the Peruvian police force disguised themselves as the Mexican superhero character El Chapulín Colorado during a drug raid in the nation's capital of Lima. Police said six members of a criminal gang were captured and that cocaine paste, marijuana, cell phones, and money were seized. 00:38 - Source: CNN Distressing images show starvation in Gaza Distressing video footage shows a 41-year-old man in Gaza who died of starvation as humanitarian organizations urge for Israel to end its blockade of the enclave. CNN's Jeremy Diamond reports. 01:57 - Source: CNN Small Irish town confronts its dark past Excavations of the remains of nearly 800 babies have begun at a former so-called mother and baby home in Tuam, Ireland. At least 9,000 infants and children died in more than a dozen of these institutions over the course of eight decades. 02:11 - Source: CNN Fire tornado rips through Turkish forest Turkey's forestry ministry has released video of a fire tornado tearing through the country's woodland. Hundreds of wildfires have gripped Turkey this summer, as well as Greece and other Mediterranean countries. 00:33 - Source: CNN Concerns grow over Australia's toxic algae bloom A harmful algae bloom off the coast of South Australia, caused by high sea temperatures and runoff from flooding, is poisoning marine life and depleting oxygen in the water. The Australian government has stated that there is little that can be done to reverse the rapid rate of the climate crisis. 01:10 - Source: CNN International visitors to US will pay new fee CNN's Richard Quest explains how the Trump administration enacted a bill that will require international visitors to pay a new 'visa integrity fee' of $250 dollars. The fee will apply to all visitors who are required to obtain nonimmigrant visas to enter the US. 01:36 - Source: CNN Mexico City residents furious over gentrification Mexico City saw its second anti-gentrification protest in less than a month on Sunday with demonstrators furious over rising prices in the city and the record number of foreigners applying for a resident visa. The main nationality of those foreigners seeking to move legally to the nation's capital? The United States of America. 01:11 - Source: CNN Child flees Israeli strike on Gaza refugee camp Video shows a child running away as Israeli munitions struck near a UNRWA school in Bureij Refugee Camp behind her. 00:36 - Source: CNN China cracks down on fake "Lafufu" Labubus Fake Labubu plush toys, dubbed "Lafufu," have gained popularity due to shortages of the original dolls made by China's Pop Mart. 02:05 - Source: CNN Jair Bolsonaro denies coup charges as police raid home Police in Brazil raided the home of former Brazilian President Jair Bolsonaro and enforced a ruling from the country's Supreme Court that Bolsonaro wear an electronic ankle tag. Bolsonaro is being accused of plotting to overturn the results of the 2022 presidential election. 01:17 - Source: CNN Taiwan conducts 10-day military drill The Taiwanese government is preparing for a war they hope will never happen. For the first time this year, Taiwan combined two major civil defense exercises, with the drills lasting ten days. These drills have included urban combat, mass casualty simulations, emergency supply drops and cyber defense that could be enacted if an invasion was to occur. CNN's Senior International Correspondent, Will Ripley, reports. 01:44 - Source: CNN Deadly flooding grips South Korea for days South Korea has been ravaged for days by intense flooding that's left more than a dozen people dead. Reuters reported more than 16 inches of rain fell in one area in just 24 hours, citing the country's Interior and Safety Ministry. 00:48 - Source: CNN Brazil's Lula tells Christiane Amanpour: Trump 'Was not elected to be emperor of the world' Brazilian President Luiz Inácio Lula da Silva tells CNN's Christiane Amanpour in an exclusive interview it was 'a surprise' to see President Donald Trump's letter posted to Truth Social, threatening Brazil with a crippling tariff of 50% starting August 1st. Lula says that he initially thought the letter was 'fake news.' Watch the full 'Amanpour' interview on CNN. 01:33 - Source: CNN Gaza's only Catholic church hit by Israeli strike Gaza's only Catholic church was struck by an Israeli tank, killing three and injuring many more, church officials said. It became internationally recognized after reports emerged that the late Pope Francis used to call the church daily. CNN's Nada Bashir reports 00:53 - Source: CNN Prince Harry recreates his mother's historic landmine walk Following in his mother's footsteps, Prince Harry visited Angola's minefields just as Princess Diana did 28 years ago. The Duke of Sussex was in Angola with The Halo Trust as part of the group's efforts to clear landmines. 00:39 - Source: CNN Massive fire destroys Tomorrowland's main stage Tomorrowland's main stage went up in flames just days ahead of the festival's opening in Boom, Belgium. 00:38 - Source: CNN How Trump's image is changing inside Russia Once hailed as a pro-Kremlin figure, President Donald Trump's image is changing inside Russia. It comes after Trump vowed further sanctions on the country if a peace agreement with Ukraine is not reached in 50 days. CNN's Chief Global Affairs Correspondent is on the ground in Moscow with the analysis. 01:41 - Source: CNN Who are the armed groups clashing in Syria? Dozens were killed in Syria this week after clashes between government loyalists and Druze militias in the southern city of Suwayda, prompting Syrian forces to intervene. That, in turn, triggered renewed Israeli airstrikes. 01:57 - Source: CNN Syrian anchor takes cover from airstrike live on TV An airstrike on the Syrian Ministry of Defense was captured live on Syria TV, forcing the anchor to take cover. Israel has been carrying out airstrikes on Syria as part of its commitment to protect the Druze, an Arab minority at the center of clashes with government loyalists. 00:30 - Source: CNN

Associated Press
13 minutes ago
- Associated Press
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the 'Company'), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that its drug candidate NV-387 is the weapon necessary for combatting growing cases of measles worldwide, especially in the industrialized world including, USA, Canada, UK, and European Union. NV-387 is possibly the only drug candidate that has been shown to be effective and safe in animal model studies of Measles virus in humanized h-CD150+ knock-in mice, as reported previously by NanoViricides. NV-387 has completed a Phase I clinical trial with no reported adverse events, indicating excellent safety and tolerability in humans. The development of NV-387 as a treatment for Measles can be accelerated under the US FDA programs. Measles is considered a rare orphan disease in the USA. As such, NV-387 for the treatment of Measles would qualify for an Orphan Drug Designation. Orphan drug designation qualifies sponsors for incentives including tax credits for qualified clinical trials, exemption from user fees, and potential seven years of market exclusivity after approval[1]. The Company also plans to explore a 'Fast Track' designation for the NV-387 Measles indication. If granted, a drug approval can occur on the basis of a successful Phase II clinical trial without requiring a Phase III clinical trial, which significantly reduces the timeline to approval. Measles has become an important disease of concern globally in the recent years for several reasons. Most importantly, Measles disease can wipe out the previously learned immunity of the patient against many infections, including from prior infections, and non-live virus vaccines, making the population vulnerable to viruses that were encountered previously. This is because Measles virus attacks the CD150-bearing immune cells that are responsible for memorizing the prior infections and mounting defenses against them later. Measles is possibly the most communicable diseases, spreading through aerosol, that is known to humans. In patients, it produces severe morbidity with skin rash, pain, fatigue, and other syndromes. Rarely it can cause a brain disease. Measles mostly affects children. There were a total of 1,319 confirmed measles cases reported in the USA as of July 22, breaking the most recent record of 1,274 cases in 2019. Hospitalization rates for measles in the USA are about 13%, and fatalities are rare, although in 2025 there were three deaths to date. Canada is having a much worse Measles season than the USA, with more than 3,800 cases[2] to date in 2025. A Measles holiday warning has been issued in the UK this year[3]. England itself had more than 3,000 cases of Measles in 2024. In the European Region, 127,350 measles cases were reported for 2024, double the number of cases reported for 2023 and the highest number since 1997, according to an analysis by WHO and the United Nations Children's Fund (UNICEF)[4] . Worldwide, Measles cases continue to occur every year. Globally, there have been about 108,000 confirmed measles cases in 2025 to date, while in 2024 there were about 360,000 confirmed cases, according to the WHO[5]. A sustained measles vaccination rate of at least 95% is estimated to be required to maintain community immunity ('herd immunity'). Such a high rate is becoming increasingly difficult to achieve even in developed countries where access to vaccination is not an issue. While growing vaccine hesitancy is considered an important reason for the fall in Measles vaccination rates, two other factors are of importance as well: (i) The overall population in the industrialized world, as well as in developing world, has increased frequency of immune dysfunction, obesity, and diabetes. The people with immune dysfunction or immune compromise are less likely to benefit from almost any standard vaccination as compared to healthy people and are likely to result in breakthrough infections. (ii) Additionally, the current vaccine for Measles is a live attenuated vaccine of the 1968 era, and the virus has evolved well past that, although so far the Measles virus strains continue to be susceptible to antibodies produced from the standard vaccine; this can change with continuing circulation of the virus in vaccinated persons and can result in a virus that can substantially defeat the vaccine[6]. Further, vaccine hesitancy itself is not irrational because the standard Measles vaccine is a live attenuated vaccine to be given to infants at early age; it is a virus infection that continues to remain in the subject, which is why it provides lifelong immunity. Measles infection itself also provides lifelong immunity that includes the current strains of the virus. Thus, the Company projects continuing Measles cases worldwide, that require a drug to control the disease in the patient and its spread to others. We believe NV-387 fills this important medical need. There is no approved drug for treatment of Measles at present. ABOUT NANOVIRICIDES NanoViricides, Inc. (the 'Company') ( ) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments. The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials. The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company's pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading 'Risk Factors' and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products. The phrases 'safety', 'effectiveness' and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA. FDA refers to US Food and Drug Administration. IND application refers to 'Investigational New Drug' application. cGMP refers to current Good Manufacturing Practices. CMC refers to 'Chemistry, Manufacture, and Controls'. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency's (EMA) committee responsible for human medicines. API stands for 'Active Pharmaceutical Ingredient'. WHO is the World Health Organization. R&D refers to Research and Development. Contact: NanoViricides, Inc. [email protected] Public Relations Contact: [email protected] press release


CBS News
an hour ago
- CBS News
Senior citizens evacuated in hot weather after electrical fire at Philadelphia apartment complex
Residents of a senior apartment complex were evacuated on a hot evening as firefighters worked to put out an electrical fire that broke out at the complex Tuesday, officials said. It's the second electrical fire at the complex in the last five weeks. The fire broke out at the Courtyard Apartments at Riverview, on South 4th Street near Washington Avenue in Queen Village, just before 7 p.m. Tuesday. It took firefighters more than five hours to get the blaze under control. Philadelphia Second Alarmers provided rehab services to firefighters as they fought through hot and humid conditions, and SEPTA brought out a cooling bus for residents. "All my food is trashed, and I'm not reimbursed, not one nickel," resident Sam Holbrook said. "No excuses given, we tried to reach the corporate office in New Jersey, and they just put a wall up." In June, hundreds of firefighters evacuated over 200 residents from the building after an electrical fire. PECO had to shut off power for several hours. "I got the text this morning, outage undetermined," Holbrook said. "That is unacceptable, because if it happened twice, it's going to happen again." We're working to find out how many people were evacuated, if the building is still without electricity, and when things will be back to normal. A spokesperson for the American Red Cross said a temporary shelter was established at Kensington High School for the Creative and Performing Arts, but was awaiting information on whether any Riverview residents used the shelter. This is a developing story and will be updated.